Search BRITE hierarchies

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
    L01 ANTINEOPLASTIC AGENTS
      L01X OTHER ANTINEOPLASTIC AGENTS
        L01XE Protein kinase inhibitors
          L01XE23 Dabrafenib [DG:DG00721]
            D10104  Dabrafenib mesylate (USAN) <JP/US>

USP drug classification [BR:br08302]
  Antineoplastics
    Molecular Target Inhibitors
      Dabrafenib [DG:DG00721]
        D10104  Dabrafenib mesylate (USAN)

Therapeutic category of drugs in Japan [BR:br08301]
  4  Agents affecting cellular function
    42  Antineoplastics
      429  Miscellaneous
        4291  Other Antitumors
          D10104  Dabrafenib mesylate (USAN); Dabrafenib mesilate (JAN)	L01XE23

Target-based classification of drugs [BR:br08310]
  Protein kinases
    Serine/threonine kinases
      TKL group
        BRAF* [HSA_VAR:673v1] [HSA:673] [KO:K04365]
          D10104  Dabrafenib mesylate (USAN) <JP/US>

[ BRITE | KEGG2 | KEGG ]